RecruitingPhase 1NCT06448780

Dose Optimization of Caffeine for HIE

Studying Neonatal hypoxic and ischemic brain injury

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of North Carolina, Chapel Hill
Principal Investigator
Wesley M Jackson, MD, MPH, MSN, DNP, FNP-C
University of North Carolina, Chapel Hill
Intervention
Caffeine citrate 20 mg/kg(drug)
Enrollment
16 target
Eligibility
All sexes
Timeline
20242028

Study locations (2)

Collaborators

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06448780 on ClinicalTrials.gov

Other trials for Neonatal hypoxic and ischemic brain injury

Additional recruiting or active studies for the same condition.

See all trials for Neonatal hypoxic and ischemic brain injury

← Back to all trials